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Cell–extracellular matrix (ECM) adhesion is mediated by transmembrane cell adhesion receptors (e.g., integrins) and receptor proximal
cytoplasmic proteins. Over the past several years, studies using biochemical, structural, cell biological and genetic approaches have provided
important evidence suggesting crucial roles of integrin-linked kinase (ILK), PINCH and CH-ILKBP/actopaxin/affixin/parvin (abbreviated as
parvin herein) in ECM control of cell behavior. One general theme emerging from these studies is that the formation of ternary protein
complexes consisting of ILK, PINCH and parvin is pivotal to the functions of PINCH, ILK and parvin proteins. In addition, recent studies
have begun to uncover the molecular mechanisms underlying the assembly, functions and regulation of the PINCH– ILK–parvin (PIP)
complexes. The PIP complexes provide crucial physical linkages between integrins and the actin cytoskeleton and transduce diverse signals
from ECM to intracellular effectors. Among the challenges of future studies are to define the functions of different PIP complexes in various
cellular processes, identify additional partners of the PIP complexes that regulate and/or mediate the functions of the PIP complexes, and
determine the roles of the PIP complexes in the pathogenesis of human diseases involving abnormal cell–ECM adhesion and signaling.
D 2004 Elsevier B.V. All rights reserved.Keywords: PINCH; ILK; Parvin; Cell –extracellular matrix adhesion; Cytoskeleton; Signaling1. Introduction
Virtually all cells in multi-cellular organisms are, at least
during certain stages of their life span, in contact with
extracellular matrix (ECM). Cell–ECM contact regulates a
variety of cellular processes including shape change, motil-
ity, proliferation, differentiation and survival. At the molec-
ular level, cell–ECM contact is mediated by transmembrane
cell adhesion receptors (e.g., integrins) and a number of
highly selective, receptor proximal cytoplasmic proteins.
These proteins are assembled into multiple complexes,
through which the ECM is physically linked to the actin
cytoskeleton and signals are transduced bi-directionally
between the ECM and the intracellular compartment [1–
11]. Identification of cell–ECM adhesion complexes, deter-
mination of their functions in various cellular processes and
elucidation of the mechanisms by which cell–ECM adhe-
sion complexes are assembled and regulated, therefore, are
of central importance to our understanding of the molecular0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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important cytoplasmic component of the cell–ECM adhe-
sions, integrin-linked kinase (ILK), was identified approx-
imately 8 years ago in a yeast two-hybrid screen based on its
interaction with the h1 integrin cytoplasmic domain [12].
Subsequently, it was found that PINCH, a protein consisting
of primarily five LIM domains [13], forms a stable complex
with ILK in cells [14,15]. More recently, it was demonstrat-
ed that PINCH, ILK and CH-ILKBP, a member of the CH-
ILKBP/actopaxin/affixin/parvin (abbreviated as parvin here-
in) family [16–19], form a ternary complex in mammalian
cells [17,20]. Over the past several years, studies from a
number of laboratories have provided important evidence
suggesting crucial roles of ILK, PINCH and parvin proteins
in ECM control of cell behavior. One important theme
emerging from these studies is that the formation of protein
complexes consisting of ILK, PINCH and parvin is pivotal
to the functions of PINCH, ILK and parvin in many, if not
all, of the cellular processes. In this review, I will discuss
our current understanding of three important aspects of the
PINCH– ILK–parvin (PIP) complexes, namely their assem-
bly, functions and regulation, and identify issues that are
pertinent to future studies in this exciting area. For other
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information on the history, structures and their roles in
specific biological and pathological processes, readers are
referred to several other reviews [15,21–26].2. Mammalian cells assemble multiple PIP complexes
PINCH [13,27], ILK [12] and parvin [16–19] are multi-
domain proteins that are widely expressed in human tissues
and well conserved in evolution [28–34]. PINCH and
parvin contain domains (five LIM domains for the former
and two CH domains for the latter) that mediate exclusively
molecular interactions. ILK, on the other hand, exhibits both
protein-binding activity and protein serine/threonine kinase
activity (reviewed in Ref. [24]). Through two specific
interactions, one mediated by the second zinc finger within
the PINCH N-terminal-most LIM1 domain and the ILK N-
terminal ankyrin (ANK) repeat domain [14,35,36], and the
other mediated by the ILK C-terminal kinase domain and
the parvin C-terminal CH2 domain [17], PINCH, ILK and
parvin form a ternary complex in cells [20] (Fig. 1).
To date, two structurally closely related PINCH proteins,
PINCH-1 [13] and PINCH-2 [27], have been identified and
cloned. PINCH-1 and PINCH-2 are encoded by two differ-
ent genes but share significant sequence similarity (human
PINCH-1 and PINCH-2 are 82% identical at the amino acid
level) [27,37]. Both PINCH-1 and PINCH-2 are widely
expressed in mammalian cells [13,27,37]. Moreover, they
are often co-expressed in the same cells [27]. PINCH-2 [27],
like PINCH-1 [14,35,36], binds to the ANK domain of ILK
(Fig. 1). The binding of PINCH-1 and PINCH-2 to ILK,
however, is mutually exclusive [27]. Thus, in cells express-
ing both PINCH-1 and PINCH-2, there exist at least two
distinctive PIP ternary complexes, one containing PINCH-1
and the other containing PINCH-2.
Mammalian parvin protein family includes three mem-
bers (a-, h- and g-parvin) that are encoded by differentFig. 1. Assembly of multiple PIP complexes in mammalian cells. This figure dep
and interactions that mediate the assembly of the PIP complexes are shown. Solid
parvin (CH-ILKBP), and ILK and h-parvin (affixin) represent known interactions.
g-parvin, which remains to be established. Up to six different PIP complexes coul
PIP complexes (the PINCH-1– ILK–CH-ILKBP and the PINCH-2– ILK–CH-ILgenes [16–19]. The three parvin proteins share significant
sequence similarity, particularly in the C-terminal region
encompassing the CH2 domain. Both a- and h-parvin,
which were also independently cloned in yeast two-hybrid
screens based on interactions with ILK (and hence were also
named as CH domain-containing ILK Binding Protein or
CH-ILKBP [17] and affixin [19], respectively), bind to ILK
through their CH2 domains. Although it remains to be tested
experimentally, given the significant sequence similarity
between g-parvin CH2 domain and the ILK-binding CH2
domains of a- and h-parvin [18], it is possible that g-parvin
might also interact with ILK. Based on tissue distribution of
human and mouse parvin mRNAs, it appears that both a-
and h-parvin are expressed in a wide variety of tissues,
whereas the tissue expression of g-parvin is more restricted,
albeit it does overlap with a- and h-parvin in at least certain
human tissues such as heart and liver [38]. Thus, it is likely
that at least in some human cells, a-, h- and possibly g-
parvin proteins are co-expressed. The presence of multiple
ILK-binding parvin proteins further expands the repertoire
of different PIP complexes (Fig. 1).3. Cellular functions of the PIP complexes
A series of recent biochemical, structural, cell biological
and genetic studies have shed new light on the cellular
functions of the PIP complexes. Based on biochemical and
structural analyses of the domains that mediate the inter-
actions between PINCH, ILK and parvin proteins, several
dominant-negative inhibitors of the PIP complexes have
been developed (Fig. 2). Expression of the dominant-nega-
tive inhibitors (e.g., the ILK-binding LIM1 containing
PINCH fragments, the PINCH-binding ANK domain-con-
taining ILK fragments, etc.) in mammalian cells effectively
disrupted the assembly of the PIP complexes [39,40].
Disruption of the PIP complexes significantly impaired cell
shape modulation, motility and ECM deposition [39,40],icts the formation of multiple PIP complexes in mammalian cells. Domains
double arrows between PINCH-1 and ILK, PINCH-2 and ILK, ILK and a-
The dashed double arrow indicates a hypothetic interaction between ILK and
d potentially be assembled in mammalian cells. The presence of at least two
KBP complexes) in the same human cells has been demonstrated [27].
Fig. 2. Dominant-negative inhibition of the PIP complexes. The PIP
complexes link the integrins to the actin cytoskeleton and mediate bi-
directional signaling between the ECM and intracellular compartment.
Dominant-negative mutants of PINCH, ILK and parvin (e.g., PINCH
fragments containing the ILK-binding LIM1 domain, ILK fragments
containing the PINCH-binding ANK domain, etc.) inhibit the formation of
the PIP complexes and thereby compromise the physical connection
between integrins and the actin cytoskeleton and the bi-directional
signaling. ILK signaling can also be inhibited by small molecule ILK
inhibitors (SM).
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plexes in cellular processes that require the integrin–actin
linkage. Additionally, small molecule ILK inhibitors have
been developed [41,42]. Inhibition of the assembly of the
PIP complexes with the dominant-negative inhibitors [40] or
that of the ILK kinase activity with small molecule or
dominant-negative ILK inhibitors reduces cell proliferation
and induces apoptosis [41,42], suggesting that ILK and its
binding partners are also critically involved in intracellular
signaling, which controls cell cycle progression and surviv-
al. A second approach that has been extremely valuable to
our understanding of the functions of PINCH, ILK, and
parvin proteins is that of genetics. In invertebrate organisms
such as Drosophila and C. elegans, mutations in genes
encoding PINCH [29,33], ILK [31,32] or parvin [34] all
result in cell–ECM attachment defects that can be attributed
to disruption of the integrin–actin linkage. Inactivation of
mouse ILK gene led to early embryonic lethality [43].
Mouse cells lacking ILK exhibited altered actin cytoskele-
ton organization, impaired cell–ECM adhesion and spread-
ing, and reduced proliferation rate [43–45]. Thus, the
cellular phenotypes induced by gene inactivation are re-
markably similar to those resulting from disruption of the
PIP complexes [39,40]. These findings suggest that the
formation of the PIP complexes is likely essential for many,
if not all, of the functions of ILK.
The findings that the PIP complexes are crucial for ECM
control of cell behavior lead to several important questions,
namely how the PIP complexes function in ECM control of
cell behavior, how the PIP complexes are recruited to ECM
adhesion sites, how the assembly of the PIP ternary com-
plexes is regulated and why cells assemble multiple PIP
complexes. Although we do not yet have complete answers
to these questions, I will attempt to summarize here recentfindings that are pertinent to answering these questions and
discuss our current understanding of these important issues.4. How do the PIP complexes function in ECM control
of cell behavior?
Two general mechanisms by which the PIP complexes
function in ECM control of cell behavior have emerged
from recent studies. First, the PIP complexes provide a
crucial physical linkage between integrins and the actin
cytoskeleton. In this regard, it is worth noting that compo-
nents of the PIP complexes are capable of interacting with
both the membrane components (e.g., h1 integrins [12]) and
the cytoskeletal components (e.g., actin [16,18], Nck-2
[46,47], paxillin [30,48] and Mig-2/UNC-112 [32,49]) of
the ECM adhesion structures. Consequently, loss of indi-
vidual components of the PIP complexes due to gene
inactivation or disruption of the assembly of the PIP com-
plexes with the dominant-negative inhibitors compromises
the integrin–actin linkage, resulting in defects in cellular
processes such as cell–ECM adhesion, spreading, migration
and fibronectin matrix assembly. Second, the PIP complexes
serve as signaling mediators that transduce signals (e.g.,
serine/threonine phosphorylation, interaction-induced con-
formational changes, etc.) to downstream effectors and
thereby control cytoskeleton organization, spreading, motil-
ity, proliferation and survival. In this regard, it is worth
noting that ILK possesses serine/threonine kinase activity
[12,50–55] and can phosphorylate several important pro-
teins including protein kinase B (PKB)/Akt [50–52], GSK-
3 [50], affixin [19], myosin light chain [51], myosin
phosphatase target subunit [54,55] and inhibitors CPI-17
and PHI-1 [53]. A protein serine/threonine phosphatase of
the PP2C family, ILKAP, can also associate with ILK [56].
Additionally, PINCH and parvins also directly or indirectly
associate with components of other signaling pathways
(e.g., small GTPase signaling pathways) [46,57–60] and
thereby modulate intracellular signaling. One of the signal-
ing proteins that can directly interact with PINCH is Nck-2
[46,47], a member of the Nck adapter protein family
[61,62]. Inactivation of the mouse Nck genes results in
embryonic developmental defects that resemble those in-
duced by the loss of components of the integrin/fibronectin
signaling pathway [63]. Thus, while Nck proteins can
interact with components of multiple signaling pathways
and are involved in a variety of cellular processes [61,62],
the interactions of Nck proteins with components of the
integrin/fibronectin signaling pathway including PINCH
[46,47] and FAK [59,64–66] likely play an important role,
particularly in the coupling of ECM adhesion to the small
GTPase signaling pathways and therefore ECM regulation
of actin cytoskeleton remodeling and motility.
While it is increasingly clear that ILK and its binding
partners are crucial in intracellular signaling, how they
function in intracellular signaling is incompletely under-
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PKB/Akt. ILK can directly phosphorylate PKB/Akt at
Ser473 [50,52], which is essential for full activation of
PKB/Akt [67]. Loss of ILK in human 293 cells and mouse
macrophages diminished the Ser473 phosphorylation of
PKB/Akt [68]. Overexpression of dominant-negative forms
of ILK also inhibited PKB/Akt activation [41,50,69]. In
addition, ILK can regulate Ser473 phosphorylation indirect-
ly [70]. Loss of a-parvin/CH-ILKBP, another component of
the PIP complex, prevented the membrane translocation of
PKB/Akt and therefore compromised the activating phos-
phorylation of PKB/Akt [71]. Thus, ILK and associated
proteins could directly or indirectly regulate PKB/Akt
activation, which likely explains, at least in part, observa-
tions that elevation in the level or the activity of ILK is
frequently associated with cancers and other hyper-prolifer-
ative and/or anti-apoptotic conditions [52,72–84]. Despite
the compelling evidence for an important role of ILK in
PKB/Akt activation in at least some cells, there is equally
compelling evidence suggesting that ILK is not the only
kinase that can phosphorylate PKB/Akt at Ser473. Expres-
sion of ILK mutants with reduced kinase activity in ILK-
deficient flies and worms fully rescued the phenotypical
defects induced by the loss of ILK [31,32,85]. Furthermore,
biochemical studies suggest that there exists a Ser473 kinase
that is distinct from ILK [86]. Finally, loss of ILK in certain
mouse cells failed to prevent the activating phosphorylation
of PKB/Akt [43,44]. Thus, while ILK is important in
promoting PKB/Akt activation in some cells, ILK is unlike-
ly an obligate kinase that is solely responsible for the Ser473
phosphorylation of PKB/Akt in some other cells. Currently,
it is not known why ILK is essential for PKB/Akt activation
in some but not other cell types. Because many studies
showing that ILK regulates PKB/Akt phosphorylation were
done in oncogenically transformed cells [41,50,52,70], it is
tempting to suggest that PKB/Akt activation depends more
heavily on ILK in cancer cells. This hypothesis, if proven
correct, could potentially provide a new strategy to selec-
tively suppress the activation of PKB/Akt in cancer cells.5. Focal adhesion recruitment and regulation of the PIP
ternary complexes
Focal adhesion proteins are recruited to cell–ECM
adhesion sites in response to cell contact with ECM, which
leads to growth and maturation of the cell–ECM adhesion
structures [7,87]. Understanding how focal adhesion pro-
teins are recruited to cell–ECM adhesion sites, therefore, is
essential for understanding focal adhesion assembly and
regulation. In mammalian cells, the assembly of the PIP
ternary complexes occurs prior to the formation of cell–
ECM adhesions [88], suggesting that PINCH, ILK and
parvin proteins are recruited to ECM adhesion sites as
pre-assembled protein complexes. Furthermore, mutations
that ablate the formation of the PIP ternary complexesabolish the ability of PINCH, ILK or parvin proteins to
localize to cell–ECM adhesions [17,27,35,88], indicating
that the formation of the PIP ternary complexes not only
precedes but also is obligate for their localization to cell–
ECM adhesions. How does the assembly of the PIP ternary
complexes promote their localization to cell–ECM adhe-
sions? One likely possibility is that it enhances the associ-
ation with cell–ECM adhesions, as components of the PIP
ternary complexes are known to interact with several other
components of cell–ECM adhesions including integrins,
actin, paxillin and Mig-2/UNC-112. In this regard, it is
worth noting that although the assembly of PIP ternary
complexes is essential for their efficient localization to cell–
ECM adhesions, there is evidence suggesting that interac-
tions with other proteins are also involved in this process
[48,88]. Additionally, the assembly of the PIP ternary
complexes also promotes the stability of the proteins [89]
and might facilitate the transport of the complex compo-
nents to cell–ECM adhesions.
How is the assembly of the PIP ternary complexes
regulated? One important regulator of the assembly of the
PIP ternary complexes appears to be protein kinase C.
Inhibition of protein kinase C down-regulates the assembly
of the PIP ternary complexes [88]. Because protein kinase C
is known to play important roles in focal adhesion assembly,
migration, proliferation and fibronectin matrix assembly
[3,90–98], processes in which the PIP complexes are
intimately involved, the identification of protein kinase C
as an upstream regulator of the PIP complexes suggests that
regulation of the assembly of the PIP complexes is likely
involved in the control of these protein kinase C-regulated
processes. Additionally, the assembly of the PIP ternary
complexes is regulated by the phosphatidylinositol-3 (PI-3)
kinase signaling pathway, as inhibition of this signaling
pathway by PI-3 kinase inhibitors or by overexpression of
tumor suppressor PTEN inhibits the interaction between
ILK and CH-ILKBP/a-parvin [99]. Given the crucial roles
of the PIP complexes in a variety of biological and patho-
logical processes, it is likely that additional regulators of the
PIP complexes will be identified in the future. Another
important area of future research is to understand the
regulation of the PIP complexes at molecular and atomic
levels. Recent studies on the three-dimensional structures of
PINCH and ILK have provided a promising start [36,47].6. Why do cells assemble multiple PIP complexes?
As discussed above, multiple PIP ternary complexes are
present in at least certain human cells. Are different PIP
complexes functionally redundant or are they playing dis-
tinct roles? Although we do not yet have a full answer to
this question, recent studies suggest that different PIP
complexes likely have distinct roles, albeit they may also
share certain common functions. For example, there exist
two different PIP complexes (PINCH-1–ILK–parvin and
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Although both PINCH-1– ILK–parvin and PINCH-2–
ILK–parvin complexes are localized at cell–ECM adhe-
sions [27,39], an elevation of the PINCH-2 expression,
which promotes the assembly of the PINCH-2–ILK–parvin
complex and concomitantly inhibits the assembly of the
PINCH-1–ILK–parvin complex, impaired cell shape mod-
ulation and migration [27]. Additionally, we have recently
found that depletion of PINCH-1 from human cells devas-
tated a number of cellular processes including cell spreading
and survival [89]. Furthermore, despite its ability to form a
complex with ILK and parvin, overexpression of PINCH-2
was unable to rescue the phenotypical defects induced by
the loss of PINCH-1 [89], suggesting that the PINCH-2–
ILK–parvin complex is incapable of substituting the
PINCH-1–ILK–parvin complex in at least some cellular
processes. Similarly, although both a- and h-parvin can
bind to ILK, there are considerable biochemical and func-
tional differences between different parvin proteins. For
example, a-, h-, and g-parvin proteins likely differ in their
ability of being phosphorylated by cyclin B1/cdc2 kinase
[100]. Functionally, depletion of CH-ILKBP (a-parvin) in
human HeLa cells, which express both a- and h-parvin (Y.
Zhang, K. Chen and C. Wu, unpublished observations),
induced apoptosis but did not inhibit cell spreading [71]. On
the other hand, depletion of either PINCH or ILK in HeLa
cells not only induced apoptosis but also impaired cell
spreading [89]. These results suggest that while the
PINCH–ILK–CH-ILKBP (a-parvin) complex plays a
prominent role in cell survival, some other PIP complexes
(e.g., PINCH–ILK–h-parvin) likely can substitute the
PINCH–ILK–a-parvin complex or even play a more
prominent role in cell shape modulation. The presence of
multiple PIP ternary complexes, each of which contains one
or two structurally and functionally related but distinctive
components (Fig. 1), provides a versatile system by which
mammalian cells can precisely control cell morphology,
motility, survival and other fundamental cellular processes
that involve the PIP complexes.7. Concluding remarks
Studies over the past several years have established the
PIP complexes as one of the key regulators of cell–ECM
communication. In addition, these studies have begun to
uncover the molecular mechanisms underlying the assem-
bly, functions and regulation of the PIP complexes. While
these studies have clearly provided an important framework
for future research, there are many important questions,
including those discussed in this review, awaiting full
answers. Among the challenges of future studies are to
define the functions of different PIP complexes in various
cellular processes, identify additional partners of the PIP
complexes that regulate and/or mediate the functions of the
PIP complexes, determine the structural basis underlying theassembly, functions and regulation of the PIP complexes
and ultimately, fully understand the molecular mechanisms
whereby the PIP complexes function in vertebrates as well
as invertebrates. A complete understanding of the assembly,
functions and regulation of the PIP complexes offers an
exciting opportunity of gaining insights into the general
mechanism governing cell–ECM adhesion and signaling.
Additionally, there is increasing evidence suggesting that
ILK and its binding partners are crucially involved in not
only cancers (reviewed in Ref. [101]) but also other path-
ological or physiological processes including renal failure
[40,102–105] and differentiation and/or functions of a
variety of cell types [69,81,106–111]. Unraveling the
mechanisms by which ILK, PINCH and parvin function in
various physiological and pathological processes represents
another challenge to cell biologists as well as clinical
investigators.Acknowledgements
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